These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

520 related articles for article (PubMed ID: 30255440)

  • 41. Progress in hepatitis C virus management in chronic kidney disease.
    Cohen-Bucay A; Francis JM; Gordon CE
    Curr Opin Nephrol Hypertens; 2021 Sep; 30(5):493-500. PubMed ID: 34054074
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Current Management of Chronic Hepatitis B and C in Chronic Kidney Disease.
    Mikolajczyk AE; Aronsohn AI
    Adv Chronic Kidney Dis; 2015 Sep; 22(5):352-60. PubMed ID: 26311596
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hepatitis C Virus Infection in Kidney Transplant Patients: Current Treatment Options.
    Dzekova-Vidimliski P; Sikole A
    Exp Clin Transplant; 2017 Dec; 15(6):587-593. PubMed ID: 29219790
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Hepatitis C virus infection in renal-transplant patients].
    Kamar N; Izopet J; Ribes D; Rostaing L
    Nephrologie; 2004; 25(1):9-15. PubMed ID: 15022868
    [TBL] [Abstract][Full Text] [Related]  

  • 45. From current status to optimization of HCV treatment: Recommendations from an expert panel.
    Craxì A; Perno CF; Viganò M; Ceccherini-Silberstein F; Petta S;
    Dig Liver Dis; 2016 Sep; 48(9):995-1005. PubMed ID: 27388261
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Treatment of hepatitis C virus infection in patients with end-stage renal disease.
    Liu CH; Kao JH
    J Gastroenterol Hepatol; 2011 Feb; 26(2):228-39. PubMed ID: 21261711
    [TBL] [Abstract][Full Text] [Related]  

  • 47. High hepatitis C viral load and genotype 2 are strong predictors of chronic kidney disease.
    Lai TS; Lee MH; Yang HI; You SL; Lu SN; Wang LY; Yuan Y; L'Italien G; Chien KL; Chen CJ;
    Kidney Int; 2017 Sep; 92(3):703-709. PubMed ID: 28532708
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hepatitis C virus infection and chronic renal disease: A review.
    Goel A; Bhadauria DS; Aggarwal R
    Indian J Gastroenterol; 2018 Nov; 37(6):492-503. PubMed ID: 30560540
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Executive summary of the 2018 KDIGO Hepatitis C in CKD Guideline: welcoming advances in evaluation and management.
    Jadoul M; Berenguer MC; Doss W; Fabrizi F; Izopet J; Jha V; Kamar N; Kasiske BL; Lai CL; Morales JM; Patel PR; Pol S; Silva MO; Balk EM; Gordon CE; Earley A; Di M; Martin P
    Kidney Int; 2018 Oct; 94(4):663-673. PubMed ID: 30243313
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Management of hepatitis C infection among patients with renal failure.
    Latt NL; Araz F; Alachkar N; Durand CM; Gurakar A
    Minerva Gastroenterol Dietol; 2015 Mar; 61(1):39-49. PubMed ID: 25390288
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Acute allograft rejection following interferon therapy for hepatitis C in recipients who have returned to dialysis after kidney transplant failure: case study.
    Fabrizi F; D'Ambrosio R; Pallotti F; Berardinelli L; Messa P; Martin P; Aghemo A
    Int J Artif Organs; 2014 Nov; 37(11):803-8. PubMed ID: 25362901
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hepatitis C virus and the kidney.
    Pol S; Parlati L; Jadoul M
    Nat Rev Nephrol; 2019 Feb; 15(2):73-86. PubMed ID: 30455426
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Management of chronic viral hepatitis before and after renal transplantation.
    Gane E; Pilmore H
    Transplantation; 2002 Aug; 74(4):427-37. PubMed ID: 12352899
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Higher risk of renal disease in chronic hepatitis C patients: Antiviral therapy survival benefit in patients on hemodialysis.
    Söderholm J; Millbourn C; Büsch K; Kövamees J; Schvarcz R; Lindahl K; Bruchfeld A
    J Hepatol; 2018 May; 68(5):904-911. PubMed ID: 29233630
    [TBL] [Abstract][Full Text] [Related]  

  • 55. New and Emerging Evidence on the Use of Second-Generation Direct Acting Antivirals for the Treatment of Hepatitis C Virus in Renal Impairment.
    Sorbera MA; Friedman ML; Cope R
    J Pharm Pract; 2017 Jun; 30(3):359-365. PubMed ID: 26902648
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treatment of Hepatitis C virus infection in Italy: A consensus report from an expert panel.
    Viganò M; Perno CF; Craxì A;
    Dig Liver Dis; 2017 Jul; 49(7):731-741. PubMed ID: 28456519
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hepatitis C virus and nonliver solid organ transplantation.
    Carbone M; Mutimer D; Neuberger J
    Transplantation; 2013 Mar; 95(6):779-86. PubMed ID: 23172130
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Association of Hepatitis C and B Virus Infection with CKD and Impact of Hepatitis C Treatment on CKD.
    Zhang H; Xu H; Wu R; Yu G; Sun H; Lv J; Wang X; Chi X; Gao X; Kong F; Zhang M; Hang L; Jiang J; Pan Y; Niu J
    Sci Rep; 2019 Feb; 9(1):1910. PubMed ID: 30760762
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Rationale for treating hepatitis C virus infection in patients with mild to moderate chronic kidney disease.
    Ridruejo E; Mendizabal M; Silva MO
    Hemodial Int; 2018 Apr; 22 Suppl 1():S97-S103. PubMed ID: 29694730
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Direct-acting antivirals for hepatitis C virus in patients on maintenance dialysis.
    Fabrizi F; Donato FM; Messa P
    Int J Artif Organs; 2017 Oct; 40(10):531-541. PubMed ID: 28708211
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.